VB Weekly 1026 Files for IPO Amid Strategic Healthcare and Tech Collaborations
Events & Perspectives
————————————————————————————————
Last week, the biggest headline was undoubtedly President Xi and his wife. The couple visited Imperial College London, a prestigious university in the UK. It is said that they couldn’t help but show their affection for each other while abroad.
Of course, what the news reported is,Imperial College London will collaborate with China on research into the application of robotics in biomedicine. Meanwhile, China will establish oncology centers in 12 of its top-tier Grade A tertiary hospitals.
Then, last Monday, in collaboration with Didi Chuxing and Mingyi Zhudao, we jointly launched the free "Didi Doctor" service.Alibaba Health, meanwhileLaunch the Future Pharmacy Partner Program, providing pharmacies with an integrated B2C+O2O (Business-to-Consumer + Online-to-Offline) internet operations platform.
It is understood that the Future Pharmacy Partner Program primarily focuses on four key areas.
First, “Partner” pharmacies leverage the extended shelf space of the B2C+O2O platform Yunyaofang (Cloud Pharmacy). Offline recommendations drive offline sales, benefiting physical pharmacies; online recommendations direct customers to offline stores, where consumers can choose either in-store pickup or express delivery.
Secondly, Alibaba Health will support “partner” pharmacies in their operational decision-making by providing assistance with store location selection, category planning, and precision marketing. Leveraging big data, these pharmacies can gain insights into the medications and daily necessities most frequently purchased by the surrounding population.
Furthermore, Alibaba Health will collaborate with domestic and international manufacturers and distributors to provide pharmacies with a suite of supporting services, including competitively priced drug supplies, logistics and distribution, financing loans, staff training, and pharmacist consultations.
Furthermore, this platform not only integrates online and offline pharmacies but also connects with medical institutions, third-party healthcare service providers, commercial insurance companies, and wearable device manufacturers, thereby creating opportunities for pharmacies to expand their business scope and innovate their operational models.
"The autumn wind is indeed bleak, making it a fitting time to huddle together for warmth."
Furthermore, there are...
Kangmei Pharmaceutical and Guangzhou University of Chinese Medicine Sign Strategic Cooperation Agreement.
Kangmei Pharmaceutical announced last week that it had recently signed a Strategic Cooperation Agreement with Guangzhou University of Chinese Medicine. The two parties will collaborate on establishing the “Kangmei Rehabilitation Hospital” project, jointly setting up the “Kangmei Research Institute,” and developing services including online hospitals, smart pharmacies, health management consulting, and comprehensive health management solutions.
Suning Partners with Pfizer to Bring Authentic Health Products into China.
According to a relevant official from Suning Global, as Pfizer’s first partner in China’s B2C e-commerce sector, Suning.com’s overseas shopping channel will launch a dedicated Pfizer section ahead of the Double 11 Shopping Festival. The initial product lineup will include nutritional and health supplements such as Centrum, Caltrate, Effervescent Tablets, Caltrate, Emergen-C, and Multi-tabs, as well as cosmetics like ChapStick.
Industry analysts believe that in the newly emerging wave of cross-border e-commerce, logistics and product trust have always been consumers' "pain points," which are particularly prominent in the field of pharmaceutical products related to user health. Logistics require international collaboration and guarantees, while the authenticity of products needs endorsement from large platforms. Now, the cooperation between Suning and Pfizer has completed the integration of supply chain procurement, logistics, payment, etc., which can effectively leverage the purchasing power of overseas shoppers.
BGI, Intel, and Alibaba Cloud Join Forces to Launch the Co-Construction of an Open Cloud Platform for Precision Medicine.
Last week, Intel Corporation, BGI Group, and Alibaba Cloud officially signed a strategic cooperation memorandum to jointly launch the co-development of an open cloud platform for precision medicine.
This platform will become the first cloud-based platform in China and even the Asia-Pacific region positioned for precision medicine applications, and it will also be a cross-boundary product that brings together the strengths of IT companies, genetic and life science institutions, and public cloud service providers.
Under the strategic cooperation memorandum, BGI will leverage its genomic data analysis cloud platform, BGI Online, released in April this year, as the foundation for collaboration. On one hand, it will integrate the platform with Intel’s high-performance computing infrastructure to create an all-in-one gene sequencing and computing system tailored for users in medical research and the healthcare industry, enabling them to conduct gene sequencing and data analysis within private environments. On the other hand, BGI Online will be deployed on Alibaba Cloud’s computing platform, which will provide a public cloud environment supported by its robust data processing and storage capabilities.
Meanwhile, there are still one or two entities “watching the fire from the other side of the river,” acting in secret.
According to showalk,Google has registered the Chinese domain name “.health” for multiple core products, including Alphabet, Google, YouTube, Android, Chrome, Gmail, and its advertising service AdSense. According to WHOIS domain queries, Microsoft has also recently registered the Chinese domain name “Microsoft.health.”
Google’s registration of Chinese-domain names appears to have raised the stakes for its return to the mainland China market. Microsoft’s involvement has further intensified the already fierce competition. To borrow an imperfect analogy,
Return to Harmony.
Recently,China Establishes Its First Academic Organization for Mobile Health.
The organization was jointly established by the Health Science Center of Peking University and the Zhongguancun Huayi Mobile Medical Technology Innovation Research Institute. Its mission is to leverage scientific research capabilities to advance mobile healthcare in China, improve the industrial ecosystem, guide technological trends, and facilitate the rapid and orderly development of China’s mobile healthcare sector.
The last one,
"Elderly Assistance Insurance": 3 yuan for one year of coverage.
Yes, you read that right.
Alipay has recently launched a new service: "Helping the Elderly Insurance." For a premium of 3 yuan, policyholders are covered for helping fallen elderly individuals at any time within one year. In the event of extortion or false accusations, they can receive up to 20,000 yuan in legal fee compensation and access to year-round legal consultation services. Surprisingly, within just a few days of its launch, 26,000 people had already purchased the insurance. One wonders: are there simply too many scammers, or is it that there are too many scammers?
VCBeat Exclusive
————————————————————————————————
Video Consultation: Innovating the Mobile Healthcare Consultation Model
The Free Model of Internet Startups Is Creating a False Prosperity
New Directions for Internet Healthcare Startups: A Comprehensive Analysis of “Second Medical Opinions”
Wharton’s Steve Barsh Reveals the 5 Common Pitfalls in Healthcare Entrepreneurship
Luo Qibin: The Catalytic Master of Big Data-Driven Product Generation
Sunshine Women and Children’s Hospital: How Physician Groups Play the O+O Game
In the pharmaceutical retail sector, it best understands what customers need.
Hotspot Frontiers: A Major Focus on the Development of Personalized Medicine
The 2nd China International Telemedicine Summit | Special Forum on China-US Dialogue
Interpretation of Trending English Terms in Digital Health:CDO
Healthcare Reform
————————————————————————————————
★Chongqing to Establish a Comprehensive Electronic Medical Record Database
The Chongqing Municipal People’s Government has released the “Implementation Plan for Advancing the Reform of the Resource Allocation Mechanism for Basic Public Services in Urban and Rural Areas of Chongqing Municipality” (hereinafter referred to as the “Plan”). The Plan calls for advancing the “Internet + Public Services” initiative, promoting networked educational services, online hospitals, and integrated medical and elderly care services in the sectors of education, healthcare, elderly care, and culture and sports.
“Internet + Education”: Exploring the Integration of Online and Offline Student Enrollment, Credit Recognition, and Credit Transfer
“Internet Plus Healthcare”: Piloting “Online Hospitals”
“Internet Plus Elderly Care Services”: Advancing the Integration of Medical and Elderly Care
“Internet Plus Culture and Sports”: Enabling the Public to Place Orders Online and the Government to Procure and Deliver Services on Demand
★Draft of the National Development and Reform Commission’s Guidance on Medical Service Pricing Completed; Expected to Be Released by Year-End
Following the State Council’s release of the “Several Opinions on Advancing the Reform of the Price Mechanism,” which called for the rationalization of medical service prices, Xu Kunlin, Director of the Price Department of the National Development and Reform Commission (NDRC), disclosed at the press conference held by the State Council Information Office on October 21 regarding the progress of price mechanism reforms that the draft guidelines for medical service price reform have been completed and are currently open for public comment. The guidelines are expected to be issued before the end of this year.
On the same day, the National Development and Reform Commission released the Central Pricing Catalog, stipulating that special drugs and blood products would be subject to central pricing, with the policy officially taking effect on January 1, 2016.
★Anhui Province Requires Hospitals to Establish Special Performance Bonuses to Encourage “Superior Service”
The Anhui Provincial Health and Family Planning Commission issued the “Notice on Implementing Special Performance-Based Incentives for Service Improvement in Public Hospitals,” requiring public hospitals to establish special performance awards. These awards will primarily recognize departments and personnel that meet performance targets in areas such as rational drug use, appropriate diagnostic testing, proper utilization of medical consumables, high-quality service delivery, and strengthened regulatory oversight. The incentive program will take effect on November 1.
★Shanxi Introduces Point-Based Management Measures for Unprofessional Practices by Medical Institutions
The Health and Family Planning Commission of Shanxi Province formulated and issued the “Administrative Measures for the Scoring of Adverse Practice Behaviors by Medical Institutions (Trial)” to further improve the regulatory mechanism for medical institution practices.
Based on the category and severity of improper practices by medical institutions, a demerit point system is implemented with six tiers: 12, 6, 4, 3, 2, and 1 points, calculated on an annual cycle. Meanwhile, supervision and management of medical institutions will be strengthened to ensure timely investigation, handling, consolidation, and recording of demerit points for any improper practices identified. A public disclosure system for demerit points related to improper practices by medical institutions will also be established to proactively accept social oversight.
★National Health and Family Planning Commission: Prices of Newly Awarded Bids Are Non-Negotiable
Recently, a draft document titled “Supplementary Notice on Several Issues in the Centralized Procurement of Medicines for Public Hospitals (Consultation Draft)” issued by the Department of Pharmaceutical Policy under the National Health and Family Planning Commission has been circulating online. The notice stated that the State Council’s Office of Healthcare Reform conducted supervisory inspections on the implementation of Document No. 7 and Document No. 70 across all provinces, autonomous regions, and municipalities directly under the central government. The inspections revealed various issues, including inconsistent understanding, uneven progress, insufficient focus on key priorities, and inadequate guidance on medicine procurement in pilot cities for public hospital reform.
Therefore, the notice reiterates the need to “adhere to the direction of centralized drug procurement and implement a unified platform with vertical coordination, transparency, and categorized procurement,” and to “persist in using the ‘Four Benefits’ as the criterion for evaluating the effectiveness of reforms and improvements in public hospital drug procurement.”
Data
————————————————————————————————
In 2020, the global market for peripheral artery disease therapies will reach an annual sales peak of $984 million.
According to a report by research consultancy GlobalData, the global peripheral artery disease (PAD) therapeutics market will grow from $543.4 million in 2014 to $983.6 million in 2020, after which it will trend downward due to the impact of generic versions of Brilinta and Xarelto, with the global PAD market projected to decline to $816.3 million by 2024.
# Longer Social Media Use in Children Linked to Higher Risk of Mental Health Issues
A report published on data collected between 2012 and 2013 indicated that 37% of children had no exposure to social media platforms, while 56% spent approximately three hours online. The remaining children spent more than three hours daily on social media, with girls exhibiting a higher degree of social media addiction than boys. The report stated that among children with the longest social media usage time, 27% scored very high on problem behavior scales, a proportion more than twice as high as the 12% observed among non-users and the 11% among those who used social media for three hours.
While social media can strengthen friendships among young people, it can also lead to mental health issues and even problems such as cyberbullying, making it a double-edged sword.
Over 1 Million Smoking-Related Deaths Annually in China; Projected to Triple by 2050
The World Health Organization, the International Tobacco Control Policy Evaluation Project, and the Chinese Center for Disease Control and Prevention jointly released "China's Smoke-Free Policies: Effectiveness Evaluation and Policy Recommendations." The report states that more than one million people in China die each year from tobacco-related diseases. If current smoking patterns persist, the number of deaths will triple by 2050.
Statistics also reveal that nearly 740 million non-smokers in China, including 182 million children, are exposed to secondhand smoke at least once a day during a typical week. Exposure to secondhand smoke causes 100,000 deaths annually in China, and it makes indoor air pollution even worse than heavily polluted outdoor environments.
Beijing Municipal Health and Family Planning Commission: By the End of August, Applications for the "Two-Child Policy for Couples Where One Spouse Is an Only Child" in Beijing Had Exceeded 50,000
According to statistical data from the Beijing Municipal Health and Family Planning Commission, the number of applications for the “selective two-child” policy in Beijing exceeded 50,000 for the first time as of August 31. Currently, appointments for maternity hospital bed registrations have been scheduled through May of next year, with very few slots remaining.
Expert analysis suggests that the current baby boom is influenced not only by the “selective two-child” policy but also by the Chinese zodiac.
Electronic Pillboxes Help Control Tuberculosis
Researchers from China and the United Kingdom recently reported in the latest issue of PLOS Medicine that a community-based trial conducted among 4,173 tuberculosis patients in China (in Heilongjiang Province, Jiangsu Province, Hunan Province, and Chongqing Municipality) showed that using electronic pillboxes to remind patients to take their medication reduced missed doses by half, thereby helping to control tuberculosis.
During the 6-month treatment period, patients who did not use any reminder measures missed 29.9% of their prescribed medication doses; those who received SMS reminders missed 27.3%. In contrast, patients using electronic pillbox reminders missed only 17%, while those using both electronic pillboxes and SMS reminders had a non-adherence rate of 13.9%.
New Technologies
————————————————————————————————
Israeli Company Develops Handheld Scanner Scio to Identify and Analyze Food Calories
An Israeli company has developed the Scio handheld scanner, which uses light beams to analyze the fat, carbohydrate, and protein content of food based on its “molecular signature.”
The device has also been sold to over 1,000 companies, allowing them to develop apps for it.
Expected to go on sale next year, Scio is now accepting pre-orders at a price of $249.
Gene Editing Technology May Hold Promise for Treating Huntington’s Disease
A new study suggests that CRISPR/Cas, a gene-editing technology that has gained significant popularity in recent years and functions as an immune system in many bacteria and archaea, may hold promise for treating Huntington’s disease, a hereditary neurodegenerative disorder. However, as the research remains in its preliminary stages, it will be some time before it can be developed into a clinically applicable therapy.
This study is quite exciting, but other researchers have issued warnings, pointing out that current CRISPR/Cas technology cannot distinguish between the normal and mutant huntingtin genes, leading to the elimination of both. Although the role of the protein encoded by the normal huntingtin gene in vivo remains unclear, its removal could still result in unpredictable side effects. Research is ongoing to further improve the technology.
Novel Wearable Pain-Relief Technology Lets You Say Goodbye to Painkillers
Neurometrix, based in Waltham, has received FDA approval for the market launch of its newly developed wearable pain-relief technology, which helps alleviate various pain conditions.
Its fundamental principle is to stimulate the sensory nerves in your legs, prompting them to release endogenous opioids—natural pain-relieving substances produced by our own bodies—which block pain signals throughout the body. In simpler terms, it manipulates the central nervous system, “commanding” it to deliver natural analgesics to the painful areas.
Common pain conditions include arthritis, neuralgia, painful diabetic neuropathy, fibromyalgia, sciatica, and back pain.
To date, the only side effect of Quell is potential skin irritation.
U.S. Scientists Develop Foam-Based Artificial Heart
Scientists at Cornell University have developed a foam-based artificial heart that closely resembles the natural heart in both shape and function.
Due to its unique material properties, the foam-based artificial heart features simple expansion and contraction mechanisms and higher operational efficiency. It would be ideal if this invention could facilitate actual production. However, this is merely the beginning; the material holds promise for future applications in fields such as soft robotics and prosthetics.
Stereoscopic Projection Technology Poised to Aid Precision Cancer Surgery
Japanese Researchers Develop Device That Uses Projection Mapping to Directly Project onto the Liver of Hepatocellular Carcinoma Patients, Distinguishing Tumor from Normal Tissue to Facilitate Accurate and Safe Surgery. The Device Is Named “Visible Light Projection Device.” In Addition to Liver Cancer, It Is Expected to Be Applied in Surgeries for Various Other Cancers, Including Breast Cancer, Lung Cancer, and Colorectal Cancer.
US Develops Wearable Sensors Capable of Monitoring Vital Signs
A team of engineers from the Cockrell School of Engineering at The University of Texas at Austin has developed a method for rapidly printing low-cost, disposable, wearable micro-biosensors. These sensors can be adhered to patients’ skin—resembling tattoos—to monitor vital signs. It is expected that these wearable sensors will soon be deployed in hospitals, replacing heart rate monitors and pulse oximeters, thereby benefiting elderly patients with heart disease and other conditions, as well as patients across other age groups.
Starling Wearable Device: Aiding Infant and Toddler Brain Development
VersaMe, a child development company based in Palo Alto, California, unveiled Starling on Indiegogo as “the world’s first educational wearable device for infants and toddlers aged 0 to 5.”
“This wearable device’s patent-pending smart algorithm can capture and count the words you speak to your child. By detecting natural pauses between syllables to determine whether a word has been spoken, it enables Starling to distinguish among multiple languages, as its primary focus is on word recognition rather than the nuances of individual words or languages.”
In addition, the accompanying VersaMe App can monitor progress or set vocabulary goals.
Capital
————————————————————————————————
